Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–Lancet Commission
Executive summary The Stanford–Lancet Commission on the North American Opioid Crisis
was formed in response to soaring opioid-related morbidity and mortality in the USA and …
was formed in response to soaring opioid-related morbidity and mortality in the USA and …
[HTML][HTML] Improving access to evidence-based medical treatment for opioid use disorder: strategies to address key barriers within the treatment system
Even though evidence-based treatment for opioid use disorders (OUD) is effective, almost
four in five Americans with OUD do not receive any form of treatment. The gap in access to …
four in five Americans with OUD do not receive any form of treatment. The gap in access to …
[HTML][HTML] Medication-Assisted Treatment for Opioid Use Disorder
National Academies of Sciences, Engineering, and … - 2018 - ncbi.nlm.nih.gov
On October 30 and 31, 2018, the Committee on Medication-Assisted Treatment (MAT) for
Opioid Use Disorder (OUD) held a 1.5-day workshop in Washington, DC. To support the …
Opioid Use Disorder (OUD) held a 1.5-day workshop in Washington, DC. To support the …
The opioid crisis: a contextual, social-ecological framework
The prevalence of opioid use and misuse has provoked a staggering number of deaths over
the past two and a half decades. Much attention has focused on individual risks according to …
the past two and a half decades. Much attention has focused on individual risks according to …
Medication treatment for opioid use disorders in substance use treatment facilities
Medication treatment (MT) is one of the few evidence-based strategies proposed to combat
the current opioid epidemic. We examined national trends and correlates of offering MT in …
the current opioid epidemic. We examined national trends and correlates of offering MT in …
[PDF][PDF] The effects of Medicaid expansion under the ACA: updated findings from a literature review
L Antonisse, R Garfield, R Rudowitz… - Published …, 2018 - nationaldisabilitynavigator.org
The tables below support the Kaiser Family Foundation February 2017 brief titled,“The
Effects of Medicaid Expansion under the ACA: Updated Findings from a Literature …
Effects of Medicaid Expansion under the ACA: Updated Findings from a Literature …
Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19
CS Davis, EA Samuels - International Journal of Drug Policy, 2021 - Elsevier
In response to the concurrent opioid overdose and COVID-19 epidemics, the United States
(US) Drug Enforcement Administration (DEA) and other federal agencies have taken steps …
(US) Drug Enforcement Administration (DEA) and other federal agencies have taken steps …
[PDF][PDF] The effects of Medicaid expansion under the ACA: updated findings from a literature review
M Guth, R Garfield, R Rudowitz - Kaiser Family …, 2020 - affordablecareactlitigation.com
At the ten year mark since the passage of the Affordable Care Act (ACA), a substantial body
of research has investigated effects of the Medicaid expansion on coverage; access to care …
of research has investigated effects of the Medicaid expansion on coverage; access to care …
Changes in buprenorphine-naloxone and opioid pain reliever prescriptions after the Affordable Care Act Medicaid expansion
Importance Expanding Medicaid eligibility could affect prescriptions of buprenorphine with
naloxone, an established treatment for opioid use disorder, and opioid pain relievers …
naloxone, an established treatment for opioid use disorder, and opioid pain relievers …
Association of Medicaid expansion with opioid overdose mortality in the United States
N Kravitz-Wirtz, CS Davis, WR Ponicki… - JAMA network …, 2020 - jamanetwork.com
Importance The Patient Protection and Affordable Care Act (ACA) permits states to expand
Medicaid coverage for most low-income adults to 138% of the federal poverty level and …
Medicaid coverage for most low-income adults to 138% of the federal poverty level and …